The nucleocapsid binds GSDMD and hinders GSDMD processing by caspase-1, therefore these insights into how SARS-CoV-2 antagonizes cellular inflammatory responses may open new perspectives for COVID-19 treatment. This evidence concerns the gene CASP1 and COVID-19.